MiR-103a-3p targets the 5′ UTR of GPRC5A in pancreatic cells

被引:113
|
作者
Zhou, Honglei [1 ]
Rigoutsos, Isidore [1 ]
机构
[1] Thomas Jefferson Univ, Computat Med Ctr, Philadelphia, PA 19107 USA
关键词
microRNAs; miRNAs; 5 ' UTR targeting; GPRC5A; miR-103a; MICRORNA-BINDING-SITES; TUMOR-SUPPRESSOR; MESSENGER-RNAS; CODING REGIONS; GENE; IDENTIFICATION; EXPRESSION; DIFFERENTIATION; TRANSLATION; RECOGNITION;
D O I
10.1261/rna.045757.114
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) are short noncoding RNAs that regulate the expression of their targets in a sequence-dependent manner. For protein-coding transcripts, miRNAs regulate expression levels through binding sites in either the 3' untranslated region (3' UTR) or the amino acid coding sequence (CDS) of the targeted messenger RNA (mRNA). Currently, for the 5' untranslated region (5' UTR) of mRNAs, very few naturally occurring examples exist whereby the targeting miRNA down-regulates the expression of the corresponding mRNA in a seed-dependent manner. Here we describe and characterize two miR-103a-3p target sites in the 5' UTR of GPRC5A, a gene that acts as a tumor suppressor in some cancer contexts and as an ongocene in other cancer contexts. In particular, we show that the interaction of miR-103a-3p with each of these two 5' UTR targets reduces the expression levels of both GPRC5A mRNA and GPRC5A protein in one normal epithelial and two pancreatic cancer cell lines. By ectopically expressing "sponges" that contain instances of the wild-type 5' UTR targets we also show that we can reduce miR-103a-3p levels and increase GPRC5A mRNA and protein levels. These findings provide some first knowledge on the post-transcriptional regulation of this tumor suppressor/oncogene and present additional evidence for the participation of 5' UTRs in miRNA driven post-transcriptional regulatory control.
引用
收藏
页码:1431 / 1439
页数:9
相关论文
共 50 条
  • [1] Two oncomiRs, miR-182-5p and miR-103a-3p, Involved in Intravenous Leiomyomatosis
    Barnas, Edyta
    Skret-Magierlo, Joanna Ewa
    Paszek, Sylwia
    Kaznowska, Ewa
    Potocka, Natalia
    Skret, Andrzej
    Sakowicz, Agata
    Zawlik, Izabela
    GENES, 2023, 14 (03)
  • [2] Circulating miR-103a-3p and miR-660-5p are associated with bone parameters in patients with controlled acromegaly
    Valassi, Elena
    Garda-Giralt, Natalia
    Malouf, Jorge
    Crespo, Iris
    Llauger, Jaume
    Diez-Perez, Adolfo
    Webb, Susan M.
    ENDOCRINE CONNECTIONS, 2019, 8 (01): : 39 - 49
  • [3] Effects of miR-103a-3p on the autophagy and apoptosis of cardiomyocytes by regulating Atg5
    Zhang, Chenjun
    Lu, Jide
    Wang, Hairong
    Qi, Yuan
    Kan, Ying
    Ge, Zhiru
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2019, 43 (05) : 1951 - 1960
  • [4] The Effect of GPRC5a on the Proliferation, Migration Ability, Chemotherapy Resistance, and Phosphorylation of GSK-3β in Pancreatic Cancer
    Liu, Bin
    Yang, Hai
    Pilarsky, Christian
    Weber, Georg F.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (07)
  • [5] microRNA-367-3p regulation of GPRC5A is suppressed in ischemic stroke
    Tabet, Fatiha
    Lee, Seyoung
    Zhu, Wanying
    Levin, Michael G.
    Toth, Cynthia L.
    Torres, Luisa F. Cuesta
    Vinh, Antony
    Hyun Ah Kim
    Chu, Hannah X.
    Evans, Megan A.
    Kuzmich, Meaghan E.
    Drummond, Grant R.
    Remaley, Alan T.
    Rye, Kerry-Anne
    Sobey, Christopher G.
    Vickers, Kasey C.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2020, 40 (06) : 1300 - 1315
  • [6] miR-103a-3p and miR-22-5p Are Reliable Reference Genes in Extracellular Vesicles From Cartilage, Adipose Tissue, and Bone Marrow Cells
    Ragni, Enrico
    Colombini, Alessandra
    De Luca, Paola
    Libonati, Francesca
    Vigano, Marco
    Orfei, Carlotta Perucca
    Zagra, Luigi
    de Girolamo, Laura
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2021, 9
  • [7] GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR
    Zhou, H.
    Telonis, A. G.
    Jing, Y.
    Xia, N. L.
    Biederman, L.
    Jimbo, M.
    Blanco, F.
    Londin, E.
    Brody, J. R.
    Rigoutsos, I.
    CELL DEATH & DISEASE, 2016, 7 : e2294 - e2294
  • [8] Serum miR-34a-5p, miR-103a-3p, and miR-376a-3p as possible biomarkers of conversion from relapsing-remitting to secondary progressive multiple sclerosis
    Agostini, Simone
    Mancuso, Roberta
    Citterio, Lorenzo Agostino
    Caputo, Domenico
    Oreni, Letizia
    Nuzzi, Riccardo
    Pasanisi, Maria Barbara
    Rovaris, Marco
    Clerici, Mario
    NEUROBIOLOGY OF DISEASE, 2024, 200
  • [9] DSCAM-AS1 accelerates cell proliferation and migration in osteosarcoma through miR-186-5p/GPRC5A signaling
    Ning, Yuwen
    Bai, Zhengfa
    CANCER BIOMARKERS, 2021, 30 (01) : 29 - 39
  • [10] TNFα, IL-6, miR-103a-3p, miR-423-5p, miR-23a-3p, miR-15a-5p and miR-223-3p in the crevicular fluid of periodontopathic patients correlate with each other and at different stages of the disease
    Costantini, Erica
    Sinjari, Bruna
    Di Giovanni, Pamela
    Aielli, Lisa
    Caputi, Sergio
    Muraro, Raffaella
    Murmura, Giovanna
    Reale, Marcella
    SCIENTIFIC REPORTS, 2023, 13 (01)